Page 4 - Ipid Management News Today

Light physical activity may be a crucial intervention target to attenuate the risk for elevated lipid levels and their sequelae in the pediatric population, study said.

Treatment with elafibranor showed significantly greater improvements in relevant biochemical indicators of cholestasis than the placebo.

Members of an indigenous community in the Bolivian Amazon have arteries that age more gradually than those of healthy, urban patients.

Only a minority of patients with psoriatic disease know about their increased risks.

New bempedoic acid and bempedoic acid/ezetimibe labels add primary hyperlipidemia and remove the maximally tolerated statin requirement and statement on the effect on mortality.

The SELECT trial catapulted GLP-1 RAs into the forefront of CVD prevention, but cardiologists are making their own decisions about whether and how they might integrate these agents into practice.

Becton Dickinson said on Thursday the FDA cleared its finger-prick blood collection device that could provide a less-invasive option for some commonly ordered lab tests.

Cross-sectional study with a diverse cohort revealed no effect modification associated with Hispanic ethnicity.

A healthy plant-based diet provided a significant reduction in LDL, as well as reductions in fasting insulin and weight compared with a healthy omnivore diet, in an 8-week controlled twin trial.

Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease.